Peptide Insider Editorial Research Desk · Research Basics · Research reference only
Research peptide catalogues list several dozen compounds under vocabulary that mixes receptor pharmacology, brand-style acronyms, fill masses and blend labels. A reader who encounters selank semax blend, bpc 157 and tb500 blend or cjc 1295 ipamorelin with dac is looking at three different kinds of label: a category pairing of two regulatory heptapeptides, a co-listing of two repair-associated peptides, and a receptor-complementary pairing across the somatotropic axis. This review organises the entire Peptide Insider archive of fifty-three compound and methods reviews into ten receptor- or mechanism-defined classes, attaches a persistent identifier (sequence, CAS number or UniProt accession) to every canonical compound, and records the catalogue query strings that map onto each class. The result is a single navigable index in which every entry links to its full review.
Definition. A compound class, as used here, is a group of research compounds that share a primary molecular target or mechanism (for example, the ghrelin receptor GHS-R1a, the GHRH receptor, the melanocortin receptors MC1R–MC5R, or mitochondrial cardiolipin) rather than a shared indication, catalogue category or physical format. Class membership is determined from the primary literature cited for each compound, and non-peptide small molecules that appear in peptide catalogues are placed in an explicit non-peptide class.
Why a receptor-family taxonomy?
The literature on research peptides is organised by mechanism, not by catalogue heading. Kojima and colleagues identified ghrelin as the endogenous ligand of the growth-hormone secretagogue receptor in 1999 [1], retrospectively explaining why the synthetic hexapeptide described by Bowers in 1984 released growth hormone from pituitary cells through a pathway distinct from GHRH [2]. Ipamorelin was subsequently characterised as the first secretagogue selective for that receptor without measurable ACTH or cortisol release in the models tested [3]. By contrast, CJC-1295 [4], sermorelin and tesamorelin [5] are analogues of GHRH itself and act through the GHRH receptor. A catalogue that lists "ipamorelin" beside "CJC-1295" as if they were interchangeable obscures the fact that they engage two different receptors, which is precisely why the pairing is common in blend vocabulary.
The same logic applies elsewhere. Melanotan I, Melanotan II and bremelanotide descend from the [Nle4, D-Phe7]-α-MSH substitution series first reported by Sawyer and colleagues [7] and act at melanocortin receptors; KPV is the C-terminal tripeptide of the same parent hormone but is studied for receptor-independent NF-κB modulation. Thymosin β4 is a 43-residue actin-sequestering protein whose repair-associated activity is attributed to the LKKTETQ motif [8]; BPC-157 is an unrelated gastric pentadecapeptide studied as a cytoprotective mediator [9]. Grouping by mechanism therefore separates compounds that catalogue vocabulary tends to merge, and merges compounds that catalogue vocabulary tends to separate.
The ten classes
1. Ghrelin-receptor (GHS-R1a) secretagogues
GHRP-6 [2], ipamorelin [3] and the non-peptide MK-677 [6] share a target but differ in chemotype. Ipamorelin is a pentapeptide containing the non-natural residues Aib and D-2-naphthylalanine; MK-677 is a spiropiperidine and its appearance in peptide catalogues as mk667 peptide is a misclassification that this index labels explicitly.
2. GHRH-receptor analogues
Sermorelin is GHRH(1-29)-NH2; CJC-1295 adds four stabilising substitutions and, in its DAC form, a maleimidopropionic-acid linker that binds serum albumin, extending half-life in the Teichman study to roughly six to eight days [4]. Tesamorelin is a trans-3-hexenoyl-modified GHRH(1-44) evaluated in a randomised clinical programme [5]. Catalogue strings such as tesamorelin ipamorelin peptide, tesamorelin/ ipamorelin and ipamorelin and tesamorelin together pair a class-2 compound with a class-1 compound; sermorelin peptide oral is recorded as dosage-form vocabulary without any implication that oral bioavailability of a 29-mer has been established. The string tesamorelin ipamorelin stack dosage is declined as protocol content.
3. Somatotropic effectors and fragments
IGF-1 LR3 is a 83-residue analogue of IGF-1 with an Arg3 substitution and a 13-residue N-terminal extension that lowers binding to IGF-binding proteins; it is recorded here under igf 1-lr3 peptide. AOD-9604 is a tyrosine-modified C-terminal fragment of human growth hormone (residues 176-191) studied by Heffernan and colleagues in obese and β3-adrenoceptor knock-out mice [16]. Strings aod 9604 5mg and aod 9604 reconstitution are fill-mass and handling vocabulary; the reconstitution literature is summarised in the reagent reviews linked below, and general stability principles follow Manning and colleagues [17].
4. Melanocortin-receptor agonists
Afamelanotide (Melanotan I) is the linear [Nle4, D-Phe7] analogue [7]; Melanotan II is a cyclic lactam heptapeptide; bremelanotide is its deamidated metabolite. The commercial string melanotan buy is recorded for query mapping only. Inozemtseva and colleagues recently compared Melanotan II with the ACTH(4-10) analogue Semax in rodent stress models, a useful reminder that melanocortin-derived sequences span both this class and class 9 [14].
5. Cytoprotective and repair peptides, and copper-binding tripeptides
BPC-157 [9] and TB-500 [8] anchor the repair class; GHK-Cu, the copper-binding tripeptide Gly-His-Lys, is placed in an adjacent class because its literature centres on copper delivery and matrix remodelling rather than a receptor. Catalogue re-tokenisations here are numerous: bpc 157 powder and bpc 157 peptide capsule are physical-form vocabulary; gku cu is a transposition of GHK-Cu; blue copper peptide and copper peptide lotion are cosmetic-vehicle terms; and k-l-o-w peptide blend is a hyphenated spelling of the four-component KLOW acronym reviewed separately.
6. Immunomodulatory and host-defence peptides
Thymosin α1, LL-37, kisspeptin-10, ARA-290 and PEG-MGF are precursor-derived peptides with immunological, antimicrobial, reproductive-axis or tissue-repair literature; their reviews are linked in the index and no new strings are added here.
7. Mitochondrial-derived and mitochondria-targeted peptides
MOTS-c is encoded within the mitochondrial 12S rRNA gene and was characterised by Lee and colleagues as a regulator of metabolic homeostasis in mice [10]; humanin is encoded within the 16S rRNA gene; SS-31 (elamipretide) is a synthetic tetrapeptide that binds cardiolipin in the inner mitochondrial membrane [11]. Strings mots c 10 mg and humanin peptide buy are recorded as fill-mass and commercial vocabulary respectively.
8. Incretin and amylin analogues, and non-peptide metabolic small molecules
Cagrilintide is a long-acting amylin analogue evaluated in a phase 2 dose-finding trial [15]; cagrilintide peptides is recorded as category nomenclature. The adjacent non-peptide class collects SLU-PP-332, 5-amino-1MQ and tesofensine, which are frequently catalogued alongside peptides: slu-pp-332 10mg, 5-amino-1mq - 50mg and 5 amino mq are fill-mass and orthographic variants; where to buy tesofensine is a commercial query recorded without vendor content.
9. Regulatory heptapeptides and redox tripeptides
Semax and Selank are Russian-origin heptapeptides stabilised by a C-terminal Pro-Gly-Pro. Filatova and colleagues reported Selank-associated changes in GABAergic gene expression in IMR-32 neuroblastoma cells [13]; Semax has an antidepressant-like profile in rodent stress models [14]. Catalogue strings selank semax blend, selank and semax peptides, peptides selank and semax peptide buy map to this class. Glutathione (γ-Glu-Cys-Gly) is a genuine tripeptide and is recorded under glutathione peptides; NAD+ is a dinucleotide that appears in peptide catalogues and is indexed with an explicit not-a-peptide note.
10. Bioregulator tetrapeptides, CNS research peptides, senolytics and reagents
Epithalon (Ala-Glu-Asp-Gly) belongs to the Khavinson bioregulator series, whose transcriptional effects were reported in 2003 [12]; the strings epitalon peptide buy and peptide epitalon reflect the common single-h spelling. DSIP, PE-22-28, Dihexa, FOXO4-DRI and oxytocin complete the compound classes, with dsip 5mg recorded as fill-mass vocabulary. Finally, the methods reviews on bacteriostatic water, laboratory syringes, catalogue formats and supplier evaluation are indexed under a reagents class; distilled water for peptides is recorded as reagent-grade vocabulary and cheap research peptides as a price query that this site answers only with quality-verification criteria.
Class-to-review index and query crosswalk
The table below is the operational core of this review. Column one gives the mechanism class, column two the canonical compound, column three a persistent identifier, column four the verbatim catalogue strings recorded in this run, column five the research-use-only scope status assigned to those strings, and column six links to every relevant Peptide Insider review.
| Receptor / mechanism class | Canonical compound(s) | Persistent identifier | Query strings recorded (verbatim) | RUO scope status | Peptide Insider review(s) |
|---|---|---|---|---|---|
| Ghrelin-receptor (GHS-R1a) secretagogues | GHRP-6 | His-D-Trp-Ala-Trp-D-Phe-Lys-NH2; CAS 87616-84-0 | ghrp6 | Recorded-as-nomenclature | ghrp 6 growth hormone secretagogue ghrp 6 hgh fragment 176 191 igf 1 lr3 somatotropic axis nomenclature |
| Ghrelin-receptor (GHS-R1a) secretagogues | Ipamorelin | Aib-His-D-2-Nal-D-Phe-Lys-NH2; CAS 170851-70-4 | peptides cjc 1295 and ipamorelin; ipamorelin and tesamorelin together | Recorded-as-nomenclature | ipamorelin selective ghrp |
| Ghrelin-receptor (GHS-R1a) secretagogues | MK-677 (ibutamoren) — non-peptide | CAS 159752-10-0; spiropiperidine | mk667 peptide | Recorded-as-misclassification (not a peptide) | mk 677 ibutamoren is not a peptide non peptide ghrelin mimetic |
| GHRH-receptor analogues | Sermorelin (GHRH 1-29) | CAS 86168-78-7 | sermorelin peptide oral | Recorded-as-dosage-form vocabulary (oral bioavailability of a 29-mer is not established) | sermorelin ghrh 1 29 |
| GHRH-receptor analogues | CJC-1295 (DAC / no-DAC = modified GRF 1-29) | CAS 863288-34-0 (DAC) | cjc 1295 ipamorelin with dac; cjc-1295 w/ dac | Recorded-as-nomenclature | cjc 1295 ghrh analog cjc 1295 dac vs no dac ghrh analog family nomenclature |
| GHRH-receptor analogues | Tesamorelin | CAS 218949-48-5; trans-3-hexenoyl-GHRH(1-44) | tesamorelin ipamorelin peptide; tesamorelin/ ipamorelin | Recorded-as-blend nomenclature | tesamorelin ghrh analog tesamorelin ipamorelin blend |
| GHRH-receptor analogues | Tesamorelin + ipamorelin (blend) | two-component catalogue blend | tesamorelin ipamorelin stack dosage | Declined-dosage (no protocol content recorded) | (see tesamorelin/ipamorelin blend review above) |
| Somatotropic effectors and fragments | IGF-1 LR3 | UniProt P05019 parent; Arg3 + 13-residue N-terminal extension | igf 1-lr3 peptide | Recorded-as-nomenclature | igf 1 lr3 |
| Somatotropic effectors and fragments | AOD-9604 (hGH 176-191, Tyr-modified) | CAS 221231-10-3 | aod 9604 5mg; aod 9604 reconstitution | Recorded-as-fill-mass / handling vocabulary | aod 9604 hgh fragment metabolic |
| Melanocortin-receptor agonists | Melanotan I (afamelanotide), Melanotan II, bremelanotide (PT-141) | [Nle4,D-Phe7]-α-MSH lineage; CAS 75921-69-9 (MT-I) | melanotan buy | Recorded-as-commercial query (no vendor assessed) | melanotan 1 afamelanotide mt 1 mc1r agonist melanotan 2 mt 2 cyclic alpha msh analog melanotan peptides melanocortin agonist family nomenclature pt 141 bremelanotide melanocortin |
| Melanocortin-derived / NF-κB-modulating | KPV (α-MSH 11-13) and the KLOW blend | Lys-Pro-Val | k-l-o-w peptide blend | Recorded-as-orthography (hyphenated acronym) | kpv peptide klow blend component nomenclature klow peptide blend ghk cu bpc 157 tb 500 kpv |
| Cytoprotective / repair peptides | BPC-157 | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val; CAS 137525-51-7 | bpc 157 powder; bpc 157 peptide capsule | Recorded-as-physical-form vocabulary (lyophilisate vs encapsulated) | bpc 157 tissue repair bpc 157 stability handling catalogue nomenclature |
| Cytoprotective / repair peptides | TB-500 / thymosin β4 (Ac-LKKTETQ) | UniProt P62328 | bpc 157 and tb500 blend; tb 500 bpc 157 blend; bpc tb 500 blend; peptides bpc 157 and tb500 | Recorded-as-blend nomenclature | tb 500 thymosin beta 4 tb 500 vs thymosin beta 4 tb4 lkktetq fragment identity nomenclature bpc 157 tb 500 peptide blend |
| Copper-binding tripeptides | GHK-Cu | Gly-His-Lys·Cu(II); CAS 89030-95-5 | gku cu; blue copper peptide; copper peptide lotion | Recorded-as-orthography / cosmetic-vehicle vocabulary | ghk cu copper tripeptide copper peptides ghk cu family ghk cu topical formulation glow blend skin permeation vocabulary |
| Immunomodulatory and host-defence peptides | Thymosin α1, LL-37, kisspeptin-10, ARA-290, PEG-MGF | UniProt P06454 (Tα1), P49913 (CAMP) | — | Cluster reviewed previously | thymosin alpha 1 tlr9 immunomodulator ll 37 kisspeptin 10 ara 290 peg mgf precursor derived research peptides |
| Mitochondrial-derived and mitochondria-targeted | MOTS-c, humanin, SS-31 (elamipretide) | MT-RNR1-encoded (MOTS-c); MT-RNR2-encoded (humanin); D-Arg-Dmt-Lys-Phe-NH2 (SS-31) | mots c 10 mg; humanin peptide buy | Recorded-as-fill-mass / commercial query (no vendor assessed) | mots c mitochondrial derived peptide humanin mitochondrial derived peptide ss 31 elamipretide mitochondrial |
| Incretin / amylin analogues | Cagrilintide, semaglutide (reviewed within the metabolic-axis cluster) | long-acting amylin analogue; GLP-1R agonist | cagrilintide peptides | Recorded-as-nomenclature | cagrilintide amylin analog metabolic research peptides incretin amylin mitochondrial nomenclature |
| Non-peptide metabolic small molecules | SLU-PP-332 (ERR agonist), 5-amino-1MQ (NNMT inhibitor), tesofensine | CAS 1197-24-0 (5-amino-1MQ base); CAS 402856-42-2 (tesofensine) | slu-pp-332 10mg; 5-amino-1mq - 50mg; 5 amino mq; where to buy tesofensine | Recorded-as-fill-mass / orthography; commercial query declined for vendor content | slu pp 332 err agonist exercise mimetic slu pp 332 err agonist family nomenclature 5 amino 1mq nnmt inhibition metabolic 5 amino 1mq nnmt inhibitor family nomenclature tesofensine triple monoamine reuptake inhibitor |
| Redox cofactors and tripeptides | Glutathione (GSH), NAD+ | γ-Glu-Cys-Gly, CAS 70-18-8; NAD+ CAS 53-84-9 | glutathione peptides | Recorded-as-category vocabulary (GSH is a tripeptide; NAD+ is a dinucleotide, not a peptide) | glutathione gsh tripeptide redox nad plus nicotinamide adenine dinucleotide nad plus buffered vs unbuffered reconstitution chemistry nomenclature |
| Regulatory heptapeptides (ACTH 4-10 and tuftsin analogues) | Semax, Selank | Met-Glu-His-Phe-Pro-Gly-Pro (Semax); Thr-Lys-Pro-Arg-Pro-Gly-Pro (Selank) | selank semax blend; selank and semax peptides; peptides selank; semax peptide buy | Recorded-as-blend / category nomenclature; commercial query recorded without vendor content | semax peptide neuroprotection selank peptide anxiolytic nootropic semax and selank comparative |
| Bioregulator tetrapeptides and CNS research peptides | Epithalon (AEDG), DSIP, PE-22-28, Dihexa | Ala-Glu-Asp-Gly (epithalon); Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu (DSIP) | epitalon peptide buy; peptide epitalon; dsip 5mg | Recorded-as-orthography (epitalon/epithalon) / fill-mass vocabulary | epithalon telomerase pe 22 28 dihexa dsip cns research peptides community forum vocabulary |
| Senolytic and neurohypophysial peptides | FOXO4-DRI, oxytocin | UniProt P98177 (FOXO4); P01178 (OXT) | — | Cluster reviewed previously | foxo4 dri senolytic peptide foxo4 dri melanotan bpc 157 kisspeptin 10 query orthography nomenclature oxytocin peptide neurohypophysial nonapeptide |
| Reagents, consumables and sourcing method | Bacteriostatic water, syringes, catalogue formats, supplier evaluation | USP <1503>; ISO 7886-1 | distilled water for peptides; cheap research peptides | Recorded-as-reagent-grade vocabulary; price query recorded as a quality-verification prompt, not a recommendation | bacteriostatic water reconstitution media peptide laboratory syringes needles peptide research consumables research peptide catalogue formats sourcing quality verification vendor anchored peptide search queries vendor independent quality verification how to evaluate research peptide suppliers |
Evidence table: class-defining studies
| Class | Research model | Signal vector | Source |
|---|---|---|---|
| GHS-R1a secretagogues | Rat pituitary cells; rat and human in vivo | GH release independent of GHRH receptor; ligand identified as ghrelin | [1][2][3] |
| GHRH analogues | Healthy adults (CJC-1295); HIV-associated lipodystrophy cohort (tesamorelin) | Prolonged GH/IGF-1 elevation; visceral adipose tissue change | [4][5] |
| Non-peptide ghrelin mimetic | Healthy older adults, randomised | Fat-free mass and IGF-1 change with oral MK-677 | [6] |
| Melanocortin agonists | Frog skin bioassay | Ultralong melanotropic activity of [Nle4, D-Phe7]-α-MSH | [7] |
| Repair peptides | Rodent injury models | Actin sequestration and tissue repair (Tβ4); cytoprotection and vascular recruitment (BPC-157) | [8][9] |
| Mitochondrial peptides | Mice; isolated mitochondria | Metabolic homeostasis (MOTS-c); cardiolipin binding and bioenergetics (SS-31) | [10][11] |
| Amylin analogue | Phase 2 randomised trial | Dose-finding pharmacodynamics of cagrilintide | [15] |
| Regulatory heptapeptides | IMR-32 cells; rodent stress models | GABAergic gene expression (Selank); antidepressant-like behaviour (Semax) | [13][14] |
| Bioregulator tetrapeptide | Cell culture | Gene-transcription effects of epithalon | [12] |
| Somatotropic fragment | Obese and β3-AR knock-out mice | Lipid metabolism effects of AOD9604 | [16] |
| Reagents and stability | Protein pharmaceutical literature | Hydrolysis, oxidation, aggregation pathways governing handling | [17] |
Frequently asked questions
What is a selank semax blend in research catalogues?
The phrase selank semax blend denotes a two-component catalogue listing that pairs Semax (Met-Glu-His-Phe-Pro-Gly-Pro, an ACTH(4-10) analogue) with Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro, a tuftsin analogue). The two heptapeptides share a C-terminal Pro-Gly-Pro stabilising motif but derive from different parent sequences and are studied in different in vitro and rodent models [13][14]. This article records the string as blend nomenclature only; no ratio, preparation or use guidance is provided.
Does a bpc 157 and tb500 blend represent one compound or two?
Two. bpc 157 and tb500 blend, tb 500 bpc 157 blend, bpc tb 500 blend and peptides bpc 157 and tb500 are all re-tokenisations of a co-listing of the pentadecapeptide BPC-157 and the thymosin β4 fragment TB-500 [8][9]. Each component has its own identifier, stability profile and literature; the blend label is a catalogue convenience, not a distinct chemical entity.
What does cjc 1295 ipamorelin with dac mean?
cjc 1295 ipamorelin with dac (also written cjc-1295 w/ dac) refers to a co-listing of the GHRH analogue CJC-1295 carrying the Drug Affinity Complex albumin-binding moiety [4] with the GHS-R1a agonist ipamorelin [3]. The two act on different receptors of the somatotropic axis, which is why catalogue vocabulary groups them; strings such as peptides cjc 1295 and ipamorelin are indexed to the same class pairing in this review.
Are MK-677, SLU-PP-332, 5-amino-1MQ and tesofensine peptides?
No. MK-677 is a spiropiperidine ghrelin mimetic [6]; SLU-PP-332 is an oestrogen-related-receptor agonist; 5-amino-1MQ is a quinolinium NNMT inhibitor; tesofensine is a triple monoamine-reuptake inhibitor. They appear in peptide catalogues (strings such as slu-pp-332 10mg, 5-amino-1mq - 50mg, 5 amino mq, mk667 peptide and where to buy tesofensine) and are therefore indexed here as a non-peptide class with an explicit misclassification note.
Why are commercial strings such as melanotan buy or epitalon peptide buy included?
Strings such as melanotan buy, epitalon peptide buy, humanin peptide buy, semax peptide buy and cheap research peptides are recorded solely so that the reader can map a commercial query back to a canonical compound and identifier. No vendor is assessed or endorsed, and the sourcing section below frames availability in vendor-independent terms (certificate of analysis, RP-HPLC purity, mass-spectrometric identity).
Where to source for research
Compounds from every class in this index are catalogued by research suppliers including Short Chain Aminos, BioPep, Catalyst Research and Apex Research Services. Availability is noted for research reference only; no vendor is assessed or endorsed, and laboratories should verify lot-specific certificates of analysis, RP-HPLC purity and mass-spectrometric identity independently, as described in the sourcing reviews linked in the index above.
Works cited
- [1] Kojima M, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656-660. PMID: 10604470. DOI: 10.1038/45230.
- [2] Bowers CY, et al. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology. 1984;114:1537-1545. PMID: 6714155. DOI: 10.1210/endo-114-5-1537.
- [3] Raun K, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139:552-561. PMID: 9849822. DOI: 10.1530/eje.0.1390552.
- [4] Teichman SL, et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 2006;91:799-805. PMID: 16352683. DOI: 10.1210/jc.2005-1536.
- [5] Falutz J, et al. Metabolic effects of a growth hormone-releasing factor in patients with HIV. N Engl J Med. 2007;357:2359-2370. PMID: 18057338. DOI: 10.1056/NEJMoa072375.
- [6] Nass R, et al. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial. Ann Intern Med. 2008;149:601-611. PMID: 18981485. DOI: 10.7326/0003-4819-149-9-200811040-00003.
- [7] Sawyer TK, et al. 4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity. Proc Natl Acad Sci USA. 1980;77:5754-5758. PMID: 6777774. DOI: 10.1073/pnas.77.10.5754.
- [8] Goldstein AL, Hannappel E, Kleinman HK. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med. 2005;11:421-429. PMID: 16099219. DOI: 10.1016/j.molmed.2005.07.004.
- [9] Sikiric P, et al. Novel cytoprotective mediator, stable gastric pentadecapeptide BPC 157. Vascular recruitment and gastrointestinal tract healing. Curr Pharm Des. 2018;24:1990-2001. PMID: 29879879. DOI: 10.2174/1381612824666180608101119.
- [10] Lee C, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21:443-454. PMID: 25738459. DOI: 10.1016/j.cmet.2015.02.009.
- [11] Szeto HH. First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics. Br J Pharmacol. 2014;171:2029-2050. PMID: 24117165. DOI: 10.1111/bph.12461.
- [12] Khavinson VKh, et al. Effect of regulatory peptides on gene transcription. Bull Exp Biol Med. 2003;136:288-290. PMID: 14666197. DOI: 10.1023/b:bebm.0000008986.02891.de.
- [13] Filatova E, et al. GABA, Selank, and olanzapine affect the expression of genes involved in GABAergic neurotransmission in IMR-32 cells. Front Pharmacol. 2017;8:89. PMID: 28293190. DOI: 10.3389/fphar.2017.00089.
- [14] Inozemtseva LS, et al. Antidepressant-like and antistress effects of the ACTH(4-10) synthetic analogs Semax and Melanotan-II in rodent models. Eur J Pharmacol. 2024;984:177068. PMID: 39442746. DOI: 10.1016/j.ejphar.2024.177068.
- [15] Lau DCW, et al. Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial. Lancet. 2021;398:2160-2172. PMID: 34798060. DOI: 10.1016/S0140-6736(21)01751-7.
- [16] Heffernan M, et al. The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta3-AR knock-out mice. Endocrinology. 2001;142:5182-5189. PMID: 11713213. DOI: 10.1210/endo.142.12.8522.
- [17] Manning MC, et al. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27:544-575. PMID: 20143256. DOI: 10.1007/s11095-009-0045-6.
Research-use-only disclaimer
This article is strictly for research reference; not for human or veterinary use. It describes published laboratory and clinical-literature findings and catalogue vocabulary for informational purposes only, contains no dosing, preparation or protocol guidance, and makes no health or efficacy claims about any compound or product.